文献速递关节外科运动医学

股骨髋臼撞击症合并临界型髋关节发育不良患者髋关节镜术后十年结局

Ten-Year Outcomes After Hip Arthroscopy in Patients With Femoroacetabular Impingement and Borderline Dysplasia.
PubMed 文献 · Am J Sports Med · 2022-02-08

本研究为病例系列(证据等级4),纳入2006年6月至2009年3月因股骨髋臼撞击症合并临界型髋关节发育不良(外侧中心边缘角20°至25°)行髋关节镜唇瓣修复的45例患者,38例在至少10年随访时获得联系(84%,平均12±1.3年)。随访显示5年避免全髋关节置换的生存率为87%,10年为79%;9例(24%)转为全髋关节置换,3例(7%)需翻修髋关节镜。年龄较大、Tönnis分级较高、软骨损伤行微骨折及Tönnis角>15°与转为全髋关节置换相关;未转为全髋关节置换者术后12年各项患者报告结局评分显著改善。

要点

  • 临界型髋关节发育不良患者髋关节镜术后10年避免全髋关节置换的生存率为79%,5年为87%。
  • 年龄较大、Tönnis分级较高、软骨损伤行微骨折及Tönnis角>15°与转为全髋关节置换相关。
  • 未转为全髋关节置换者在12年随访时改良Harris髋关节评分等显著改善。

核心结论

  • 临界型髋关节发育不良患者髋关节镜术后转为全髋关节置换的风险因素包括年龄较大、Tönnis分级较高、软骨损伤行微骨折及Tönnis角>15°;未转为全髋关节置换者10年时结局指标改善,作者认为仔细的患者选择对该手术成功至关重要。

研究设计与样本

  • 病例系列,证据等级4;纳入2006年6月至2009年3月因股骨髋臼撞击症合并临界型髋关节发育不良(外侧中心边缘角20°至25°)行初次髋关节镜唇瓣修复、年龄18至70岁的髋关节,排除既往髋部手术、股骨头缺血性坏死或骨折者。

主要发现

  • 45例符合纳入标准,38例在至少10年术后获得联系(84%;平均±标准差,12±1.3年),其中女23例、男15例,平均年龄41±9.6岁(范围25-69),20例≥40岁。
  • 38例中9例转为全髋关节置换(24%),3例需翻修髋关节镜(7%);5年避免全髋关节置换生存率87%,10年79%。
  • 年龄、Tönnis分级、软骨损伤行微骨折及Tönnis角>15°与转为全髋关节置换相关。
  • 转为与未转为全髋关节置换者在外侧中心边缘角、Sharp角或alpha角方面无统计学显著差异。
  • 随访12年(范围10-13)时改良Harris髋关节评分从58升至83(P=0.002),髋关节结局评分-日常生活活动从70升至87(P=0.003),髋关节结局评分-运动从47升至76(P=0.004),西安大略和麦克马斯特大学骨关节炎指数从31降至10(P=0.001)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The role of hip arthroscopy in the treatment of patients with borderline hip dysplasia is controversial and evolving. PURPOSE: To evaluate outcomes at a minimum 10-year follow-up in patients who underwent hip arthroscopy for femoroacetabular impingement in a hip with borderline dysplasia. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: All hips that underwent labral repair between June 2006 and March 2009 for femoroacetabular impingement with borderline dysplasia were included if they had a lateral center-edge angle of 20° to 25°, had primary hip arthroscopy for the diagnosis of femoroacetabular impingement, and were aged 18 to 70 years. Patients were excluded if they had previous hip surgery, avascular necrosis, or fracture. Kaplan-Meier survivorship was performed, with survivorship defined as avoidance of conversion to total hip arthroplasty (THA). RESULTS: A total of 45 patients met the inclusion criteria, and 38 were contacted at a minimum 10 years postoperatively (84%; mean ± SD, 12 ± 1.3 years). There were 23 women and 15 men with an average age of 41 ± 9.6 years (range, 25-69). Twenty patients were ≥40 years of age. In this patient cohort, survivorship was 87% at 5 years and 79% at 10 years for conversion to THA. Of the 38 patients included, 9 were converted to THA (24%), and 3 required revision hip arthroscopy (7%). Patient age, Tönnis grade, microfracture of cartilage lesions, and Tönnis angle >15° were associated with conversion to THA. No statistically significant differences were found between those who underwent conversion to THA and those who did not regarding lateral center-edge angle, Sharp angle, or alpha angle. Significant improvements were seen at follow-up of 12 years (range, 10-13) for the modified Harris Hip Score (58 to 83; P = .002), Hip Outcome Score-Activities of Daily Living (70 to 87; P = .003), Hip Outcome Score-Sport (47 to 76; P = .004), and Western Ontario and McMaster Universities Osteoarthritis Index (31 to 10; P = .001). At follow-up, >80% maintained the minimal clinically important difference for the Hip Outcome Score (Activities of Daily Living and Sport) with no differences between patients aged <40 and ≥40 years. CONCLUSION: Risk factors for conversion to THA after hip arthroscopy in the borderline dysplastic hip included older age, higher Tönnis grades, grade 4 chondral lesions that were microfractures, and Tönnis angle >15°. In those patients who did not convert to THA, improvement in outcome measures was seen at 10 years. Careful patient selection is critical to the success of this procedure.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Beals TR, Soares RW, Briggs KK, et al. Ten-Year Outcomes After Hip Arthroscopy in Patients With Femoroacetabular Impingement and Borderline Dysplasia. Am J Sports Med. 2022. PMID: 35133204. doi:10.1177/03635465211068109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。